InvestorsHub Logo
Followers 83
Posts 5662
Boards Moderated 1
Alias Born 10/17/2006

Re: None

Friday, 03/31/2017 5:26:13 PM

Friday, March 31, 2017 5:26:13 PM

Post# of 32016
All the discussion these days, about the next big (LOL!) thing, for Mannkind is a pediatric study for Afrezza.

Lots of threads about it, for example:
http://mnkd.proboards.com/thread/7419/pediatric-study

You might be looking for clues about demand. Sanofi started an FDA trial, and left it open for enrollment for months. How many applicants did they get who were willing to get Afrezza for free?

Hundreds!

Thousands!

No, two people signed up.

Afrezza really is the drug you can't give away.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y